期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

静脉血栓栓塞的再发风险 被引量：3

下载PDF
导出
摘要 现已明确发生静脉血栓栓塞（venous thromboembolism,VTE）之后数周是再发静脉血栓风险（再发风险）最高的时段,以后随着时间的延长而有所下降。再发风险可以通过抗凝治疗而得到预防,但治疗过程中也可能发生严重或致命的出血风险。
作者 石建平 赵梦华 陈海鱼
机构地区 河北省邯郸市中心医院心内科
出处 《中国循证心血管医学杂志》 2012年第1期75-77,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 静脉血栓栓塞 再发风险 抗凝治疗 出血
分类号 R543.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献30

  • 1Kearon C,Kahn SR,Agnelli G,et al.American College of ChestPhysicians.Antithrombotic therapy for venous thromboembolic dis-ease[J].Chest,2008,133(6 Suppl):454S-545S.
  • 2Hull R,Delmore T,Genton E,et al.Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis[J].N Engl J Med,1979,301(16):855-858.
  • 3Flinterman LE,van Hylckama Vlieg A,Rosendaal FR,et al.Recur-rent thrombosis and survival after a first venous thrombosis of theupper extremity[J].Circulation,2008,118(13):1366-1372.
  • 4Eichinger S,Weltermann A,Minar E,et al.Symptomatic pulmonaryembolism and the risk of recurrent venous thromboembolism[J].Arch Intern Med,2004,164(1):92-96.
  • 5Jimenez D,Diaz G,Marin E,et al.The risk of recurrent venousthromboembolism in patients with unprovoked symptomatic deepvein thrombosis and asymptomatic pulmonary embolism[J].Thromb Haemost,2006,95(3):562-566.
  • 6Douketis JD,Gu CS,Schulman S,et al.The risk for fatal pulmonaryembolism after discontinuing anticoagulant therapy for venousthromboembolism[J].Ann Intern Med,2007,147(11):766-774.
  • 7Murin S,Romano PS,White RH.Comparison of outcomes after hos-pitalization for deep venous thrombosis or pulmonary embolism[J].Thromb Haemost,2002,88(3):407-414.
  • 8Agnelli G,Prandoni P,Becattini C,et al,Warfarin Optimal DurationItalian Trial Investigators.Extended oral anticoagulant therapy aftera first episode of pulmonary embolism[J].Ann Intern Med,2003,139(1):19-25.
  • 9Hansson PO,Sorbo J,Eriksson H.Recurrent venous thromboembo-lismafter deep vein thrombosis:incidence and risk factors[J].ArchIntern Med,2000,160(6):769-774.
  • 10PREPIC Study Group.Eight-year follow-up of patients with perma-nent vena cava filters in the prevention of pulmonary embolism:thePREPIC(Prevention du Risque d Embolie Pulmonaire par Inter-ruption Cave)randomized study[J].Circulation,2005,112(3):416-422.

同被引文献35

  • 1党永康,乌兰,杨柳,姜学超.利伐沙班治疗静脉血栓栓塞症患者的临床疗效[J].血管与腔内血管外科杂志,2020,6(3):213-216. 被引量：3
  • 2玉素甫江 买塞地,方青波,慈红波,戈小虎.急性下肢深静脉血栓的诊断与治疗进展[J].血管与腔内血管外科杂志,2019,5(6):535-539. 被引量：11
  • 3Kahn SR,Shrier I,Julian JA,et al.Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis[J].Ann Intern Med,2008,149(10):698-707.
  • 4Morris TA.New synthetic antithrombotic agents for venous thromboembolism:pentasaccharides,direct thrombin inhibitors,direct Xa inhibitors[J].Clin Chest Med,2010,31(4):707-18.
  • 5Schulman S,Kearon C,Kakkar AK,et al.Dabigatran versus warfarin in the treatment of acute venous thromboembolism[J].N Engl J Med,2009,361(24):2342-52.
  • 6Khorana AA.Venous thromboembolism and prognosis in cancer[J].Thromb Res,2010,125(6):490-3.
  • 7Enden T,Klow NE,Sandvik L,et al.Catheter-directed thrombolysis vs.anticoagulant therapy alone in deep vein thrombosis:results of an open randomized,controlled trial reporting on short-term patency[J].J Thromb Haemost,2009,7(8):1268-75.
  • 8Turpie AG,Levine MN,Hirsh J,et al.Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis:results of a randomized trial[J].Chest,1990,97(suppl):172S-5S.
  • 9Mewissen MW,Seabrook GR,Meissner MH,et al.Catheter-directed thrombolysis for lower extremity deep venous thrombosis:report of a national multicenter registry[published correction appears in Radiology[J].Radiology,1999,211(1):39-49.
  • 10Comerota AJ,Throm RC,Mathias SD,et al.Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves healthrelated quality of life[J].J Vasc Surg,2000,32(1):130-7.

引证文献3

二级引证文献19

中国循证心血管医学杂志
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部